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Objective: To investigate the expression of HIP/PAP in hepatocellular carcinoma (HCC)
patients and explore its role in migration and invasion of HCC.
Methods: The expression of HIP/PAP in HCC tissue and corresponding adjacent
noncancerous tissue was assessed by IHC, RT-PCR and Western blot. The correlation
between clinicopathological features and HIP/PAP expression was analyzed. The role of
HIP/PAP on invasion and migration of HCC cells was observed by RNA interference,
wound healing and Transwell assay.
Results: Both mRNA and protein expression of HIP/PAP was upregulated in HCC
tissues compared to tumor-adjacent tissue and correlated with poor tumor differentiation,
advanced tumor stage and vascular invasion. HIP/PAP expression was also upregulated in
HCC cells, and silencing its expression by speciﬁc siRNA could inhibit the invasion and
migration of HCC cells.
Conclusions: HIP/APA is overexpressed in HCC and contributes to the migration and
invasion of HCC cells.1. Introduction
Hepatocellular carcinoma (HCC), the most common type of
primary liver carcinoma, is a leading cause of morbidity and
mortality worldwide. Due to the prevalence of viral hepatitis,
China has the largest HCC population in the world [1]. Despite
numerous advances have been made regarding the diagnostic
and therapeutic methods during the past decades, the
prognosis of HCC patients is still not improved due to the
high rate of recurrence and metastasis [2]. The Insidious onset
of early-stage HCC makes it difﬁcult to diagnose, and a num-
ber of HCC patients have lost opportunity of surgery at the time
of diagnosis due to intrahepatic or distant metastasis [3]. The
increasing researches into molecular targeting therapy have
opened a new era for the treatment of HCC, and thoroughly
understanding the molecular mechanisms of migration and
invasion of HCC is basis of targeting therapy [2].
Human hepatocarcinoma-intestine-pancreas/pancreatitis-
associated protein (HIP/PAP), also known as Reg3A, amember of regenerating gene (Reg) family [4], was initially
described as an acute phase secretory protein expressed during
acute pancreatitis. Under physiological condition, HIP/PAP is
mainly secreted by intestine and pancreas, promoting
regeneration of intestinal epithelial cells and maintaining the
integrity of Intestinal barrier [5]. Later, researches have shown
the expression of HIP/PAP is upregulated in some digestive
system carcinoma (colorectal carcinoma, HCC, pancreatic
carcinoma) [4,6]. In recent years, HIP/PAP is profoundly
studied as a pleiotropic molecule with mitogenic, anti-
apoptotic and antimicrobial potential [7–10], the mitogenic and
anti-apoptotic activity can ameliorate acute pancreatitis
induced by cerulean and promote regeneration of hepatocytes
after partial hepatectomy [7], and protects mice from
acetaminophen induced liver injury [11], however it also can
promote proliferation and inhibit apoptosis of cancer cells [12].
HIP/PAP is overexpressed in human HCC but not in normal
adult liver, and its serum level is also elevated [13]. Previous
studies have revealed that in HCC cells HIP/PAP can inhibit
apoptosis induced by TNF-a and promote proliferation by
up-regulating the expression of Cyclin A [11], suggesting its
critical role in the carcinogenesis and progression of HCC.
In this study, we investigated expression of HIP/PAP in
HCC tissue and cells, and explore its role in migration and
invasion.open access article under the CC BY-NC-ND
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2.1. Ethical statement
All protocols were approved by the Institutional Animal Care
and Use Committee of Soochow University. All patients gave
fully consent to the research.
2.2. Clinical specimens and HCC cells
A total of 75 pairs (50 males and 25 females, range 32–74 year
old; median 55.6 year old) of surgically resected HCC and adja-
cent liver tissue were collected from Department of General
Surgery, First Afﬁliated Hospital of Soochow University during
2013–2015. None of these patients received any radiotherapy,
chemotherapy or radiofrequency ablation before surgery. HCC
tissues and matched adjacent noncancerous tissues (at least 2 cm
away from the surgical border) were immediately ﬁxed in 4%
paraformaldehyde (dissolved in PBS solution) or stored in −80 C
refrigerator for further research. Besides, the clinicopathological
characteristics were also recorded. Staging and differentiation of
the tumor was based on the TMN standard (Union for Interna-
tional Cancer Control) and Edmondson method respectively.
Human immortalized liver cell line LO2 and 4 HCC cell lines
(Huh7, HepG2, Hep3B and SMMC-7721) were purchased from
the Institute of Biochemistry and Cell Biology, Chinese Acad-
emy of Sciences (Shanghai, China). Cells were cultured in
complete DMEM medium with 10% fetal bovine serum (Gibco
BRL, Gaithersburg, MD, USA) at 37 C, 5% CO2.
2.3. Immunohistochemistry assay
Paraformaldehyde-ﬁxed and parafﬁn-embedded sections were
used to in immunohistochemical assay (SP-IHC method). Sec-
tions were deparafﬁnized in xylene and rehydrated in a series of
ethanol with decreasing concentration, and then undergone anti-
gen retrieval in citrate buffer for 15 min at 95 C. Sections were
treated in 3% H2O2 to quench endogenous peroxidase and incu-
bated with HIP/PAP primary rabbit polyclonal antibody (Abcam,
1:100) for overnight at 4 C, then incubated with biotinylated IgG
secondary antibody (ZYMED, USA) then horseradish peroxidase
conjugated streptavidin, then color development with DAB so-
lution. HIP/PAP primary rabbit polyclonal antibody was replaced
with PBS solution for negative control.
Sections were checked by two pathologists blind to the
clinical situation of all patients. The staining result for the HIP/
PAP protein was semi-quantitatively assessed by Mattern
method: intensity score × percentage score. The intensity score
was expressed in the following four grades: 0 = none; 1 = weak;
2 = moderate; and 3 = strong. The percentage score (percentage
of positively-stained cells) was expressed as the following
grades: <5%, 0; 6%–25%, 1; 26%–50%, 2; 51%–75%, 3;
4 > 75%, 4. The average score of ten high magniﬁcation (×400)
ﬁelds in each section became the ﬁnal score. The overall score
1 was deﬁned as HIP/PAP positive.
2.4. Real time polymerase chain reaction (RT-PCR)
Total RNA was extracted from HCC specimens or HCC cells
by TRIZOL reagent (Invitrogen) following manufacturer's in-
structions. RNA concentration was determined to ensure equalamount of RNA was added in reverse transcription PCR. The
cDNA was synthesized using the Revertid™ First Strand cDNA
Synthesis Kit (Fermentas, Burlington, ON, Canada) at 37 C for
30 min. Following inactivation at 94 C for 2 min, Real-time
PCR was performed to amplify and quantify the cDNA of
each sample using SYBR® Premix Ex Taq™ II (Takara, Japan)
at 94 C for 30 s, 60 C for 30 s, 72 C for 45 s with a total of 30
cycles, and a ﬁnal extension at 72 C for 10 min. The human b-
actin gene was used as a internal control. Quantitative RT-PCR
was performed at least three times per sample with three repli-
cations each time. The relative gene expression was calculated
with the 2−DDCt method. The primers were synthesized by Augct
Bio-tech (Beijing, China), the sequence of primers listed as
follow, HIP/PAP (351 bp): Sense 50-CCACCAGA-
GAGTGACTC-30, antisense 50-GAGTAGCTGTTACCAATG-
30; b-actin (416 bp): Sense 50-GAGCTACGAGCTGCCT-
GACG-30, Antisense 50-CCTAGAAGCATTTGCGGTGG-30.
The PCR product was visualized on 2% agarose gel.
2.5. Western blotting analysis
Total protein of cultured cells or tissues was extracted by
RIPA Lysis Buffer (Beyotime Biotechnology, Beijing, China).
Protein concentration was determined by the BCA assay kit
(Beyotime Biotechnology, Beijing, China). A total of 60 mg
protein was separated by 12% SDS-PAGE electrophoresis and
transferred to Polyvinylidene Fluoride membranes. Membranes
were blocked by Tris-buffered saline–Tween 20 containing 5%
skim milk and probed with HIP/PAP (Abcam, ab134309, 1:500)
or b-actin (Santa Cruz, sc-7210, 1:2000) antibody. Secondary
horseradish peroxidase-conjugated goat anti-rabbit antibody
(Santa Cruz, sc-2004) was used at a 1:10000 dilution and
detected by the Enhanced Chemiluminescence Reagent (Milli-
pore, Billerica, MA, USA).
2.6. siRNA transfection
Speciﬁc siRNA of HIP/PAP and scramble siRNA as nega-
tive control were synthesized by Augct Bio-tech (Beijing,
China). Cells were seeded in 6-well plates (2 × 105 cells per
well), and transfected with 100 pmol siRNA (HIP/PAP siRNA
or scramble siRNA) by Lipofectamine 2000 method (Invi-
trogen, Carlsbad, CA, USA) following manufacturer's in-
structions, and continued to culture in the incubator at 37 C,
5% CO2. Reduced serum medium was replaced with complete
medium after 6 h. Cells were harvested after 48 h. The effect of
siRNA was tested by RT-PCR and western blotting. The spe-
ciﬁc siRNA against HIP/PAP sequence (50–30): GUGAA-
GAGCAUUGGUAACAGCTAdTdT, Scramble siRNA
sequence (50–30): UUCUCCGAACGUGUCACGUdTdT.
2.7. Wound healing assay
Cells were cultured and transfected with HIP/PAP siRNA or
scramble siRNA, then seeded in 6-well plates and allowed to
grow into cell monolayer overnight. A wound was created by a
yellow sterile pipette tip on the surface of plates, and the sus-
pended cells were gently cleared with PBS. Cells in the plates
were cultured in serum-free medium. Images of wound were
taken under the phase-contrast microscope at 0, 24 and 48 h. The
distance was measured by Image Pro-Plus 6.0 software (Media
Table 1
Correlation of HIP/PAP expression with clinicopathological character-
istics of 75 HCC cases.
Clinical
parameters
Cases
(n)
Expression level P
value
Positive
(n = 51)
Negative
(n = 24)
Age (years)
<65 years 50 35 15 0.610
65 years 25 16 9
Gender
Male 50 34 16 1.000
Female 25 17 8
Tumor size (cm)
<5 cm 47 35 12 0.134
5 cm 28 16 12
Tumor number
Solitary 43 28 15 0.621
Multiple 32 23 9
Edmondson
Ⅰ+Ⅱ 30 12 18 0.001*
Ⅲ+Ⅳ 45 39 6
TNM stage
Ⅰ–Ⅱ 49 28 21 0.008*
Ⅲ–Ⅳ 26 23 3
Capsular inﬁltration
Present 44 31 13 0.622
Absent 31 20 11
Vascular invasion
Present 40 22 18 0.013*
Absent 35 29 6
AFP
<400 ng/mL 28 19 9 1.000
400 ng/mL 47 32 15
HBsAg
Positive 62 43 19 0.745
Negative 13 8 5
*P < 0.05.
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repeated wells were measured with three replications.
2.8. Migration and invasion assay
24-well transwell (8-mm pore size; Millipore) was used to
perform migration assay and Matrigel invasion assay. Matrigel-
coated chamber was prepared following manufacturer's in-
structions. For migration assay, 24 h after transfection, the con-
centration of cells was adjusted to 2.5 × 105/mL by DMEM fetal
bovine serum-free medium, 100 mL cell suspension was loaded
into the top chamber of transwell insert with non-coated mem-
brane. For invasion assay, 100 mL cell suspension was loaded into
the upper Matrigel-coated chamber instead. In both assays,
600 mL DMEM with 10% fetal bovine serum was added into the
bottom chamber. Cells were then allowed to migrate or invade for
48 h at 37 C. The cells that migrated or invaded into the bottom
chamber were ﬁxed in paraformaldehyde and permeabilized in
methanol, then stained with crystal violet dye. Images were taken
and penetrated cells were counted under a light microscope. The
average cell number of four random ﬁelds was the ﬁnal result.
2.9. Statistical analysis
Data was expressed as mean ± SD. Difference analysis was
performed by SPSS 18.0. Difference was considered statistically
signiﬁcant when P < 0.05.
3. Results
3.1. HIP/PAP expression in HCC tissues
To observe the expression of HIP/PAP in HCC tissues, HIP/
PAP expression at mRNA and protein level was assessed inFigure 1. mRNA and protein expression of HIP/PAP in HCC tissues.
(A) Representative IHC staining and IHC scores ofHIP/PAP expression in humanHCC tissues and tumor-adjacent liver tissues, Originalmagniﬁcation: ×400; (B)
Comparison of mRNA expression of HIP/PAP between HCC tissues and tumor-adjacent liver tissues; (C) Expression of HIP/PAP protein in HCC tissues and
adjacent noncancerous tissues (N: adjacent noncancerous tissue, T: HCC tissue), Representative western blotting ﬁlm (n = 3) and relative level of expression.
Figure 2. HIP/PAP expression in HCC cell lines and downregulation of HIP/PAP in Hep3B and Huh7 cells by speciﬁc siRNA.
(A) Real-time PCR analysis of HIP/PAP expression in different HCC cell lines; (B) Western blotting analysis of HIP/PAP expression in different HCC cell
lines. Expression of HIP/PAP is remarkably downregulated in Hep3B and Huh7 cells by speciﬁc siRNA reﬂected by HIP/PAPmRNA quantiﬁcation by real-
time PCR (C) and HIP/PAP protein analysis by Western blotting (D). (**P < 0.001, *P < 0.05).
Figure 3. Motility of HCC cells measured by wound healing assay.
Wound healing assays revealed that the migration of Huh7 cells (A) and Hep3B cells (B) was inhibited by HIP/PAP silencing, original magniﬁcation ×100
(*P < 0.01).
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immunohistochemistry and western blot. Immunohistochemical
staining (Figure 1A) of HIP/PAP could be detected in both
cytoplasm and intercellular space. As shown in Figure 1B and C,
both HIP/PAP mRNA and protein expression elevated signiﬁ-
cantly in HCC tissue compared with matched adjacent noncan-
cerous tissues.
3.2. HIP/PAP expression correlates with poor
clinicopathological features
Correlation analysis (Table 1) showed that positive HIP/PAP
expression in HCC tissue was signiﬁcantly associated with poor
differentiation, advanced tumor stage and vascular invasion,
however HIP/PAP expression was not associated with gender,
age, serum AFP or tumor number and size. These resultsFigure 4. Migration and invasion of HCC cells measured by Transwell assay.
Migrated and invaded cells were stained with crystal violet and imaged by mic
PAP knockdown by speciﬁc siRNA signiﬁcantly inhibits migration (A) and indemonstrated that elevated HIP/PAP expression correlated with
aggressive behaviors of HCC.
3.3. HIP/PAP expression in HCC cells and effect of
siRNA on HIP/PAP expression in Huh7 and Hep3B cells
The result showed HIP/PAP mRNA (Figure 2A) and protein
(Figure 2A) level were increased remarkably in HCC cells, HIP/
PAP expression was signiﬁcantly higher in Hep3B and Huh7
cells which possessed higher invasive behavior. Speciﬁc HIP/
PAP siRNA and scramble were transfected into Huh7 and
Hep3B cells, effect of RNA interfering was evaluated by RT-
PCR and western blot. As shown in Figure 2C and D, HIP/
PAP-siRNA signiﬁcantly down-regulated HIP/PAP mRNA
and protein expression in Huh7 and Hep3B cells, and could be
used for subsequent experiments.roscopy, original magniﬁcation ×100. Representative images showed HIP/
vasion (B) of Hep3B and Huh7 cells (*P < 0.01).
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invasion of Huh7 and Hep3B cells
Wound healing assay (Figure 3) demonstrated that HIP/PAP
knockdown could inhibit the motility of Huh7 and Hep3B cells.
Transwell assay also revealed HIP/PAP knockdown by siRNA
in the highly invasive Huh7 and Hep3B cells could signiﬁcantly
inhibited the migratory (Figure 4A) and invasive (Figure 4B)
behavior compared to control group.
4. Discussion
Tumor is a major cause of death worldwide, and HCC is one
of the worst due to its rapid growth, early metastasis and
relapse. The poor prognosis of HCC patients is mainly due to
metastasis. Understanding the molecular mechanism of HCC
carcinogenesis, progression and metastasis is top priority for
advancing the therapeutic pattern. Growing studies indicated
that cancer-related inﬂammation (tumor inﬂammatory micro-
environment) plays pro-tumoral role, and tumor in a self-
sufﬁcient way promotes the expression of inﬂammatory medi-
ators associated with proliferation and survival of malignant
cells, angiogenesis, and metastasis [14–16]. The fact that most
HCC cases having either HBV, HCV infection or alcoholic
liver disease indicates that hepatic inﬂammation and ﬁbrosis is
the major risk factor of HCC carcinogenesis and progression
[17], however the mechanistic basis of the association between
inﬂammation and cancer are not completely understood,
Inﬂammation-ﬁbrosis-cancer axis is a recently-proposed
pattern to explain the mechanism regarding how hepatic
inﬂammation contributes to cancer. Chronic hepatocyte damage
leads to the continuous release of inﬂammatory mediators (such
as TGF-b, TNF-a, IL-6, CXCL1, CXCL2) which augment he-
patocyte damage and promote ﬁbrosis and cirrhosis, stimulating
regeneration and malignant transformation of hepatocytes
[16,18]. Nuclear factor-kB (NF-kB) is the pivotal transcription
factor in the inﬂammation-ﬁbrosis-cancer axis and can act as
signal transducer for a number of membranous receptors,
studies have demonstrated inﬂammatory mediators which
compose inﬂammatory microenvironment are mainly released
by activation of NF-kB pathway. Toll like receptors are the
major upstream receptors of NF-kB. HIP/PAP is an important
molecular component of the tumor inﬂammatory microenvi-
ronment, and can be secreted through Toll like receptors – NF-
kB pathway [19].
HIP/PAP has a variety of biologic activities, and commonly
expressed in digestive system malignancies. Similar to other
oncogenes, the expression of HIP/PAP is high in embryonic
stage of liver development, but restrained in normal adult liver.
The elevated expression of HIP/PAP in cirrhotic patients before
HCC development suggests that HIP/PAP is not just a marker of
HCC, but also a promoter in the carcinogenesis of HCC, how-
ever the detailed molecular mechanisms are still unknown.
Previous researches have conﬁrmed that HIP/PAP exerts pro-
liferative potential by up-regulating Cyclin A [8,10], yet its role in
HCC migration and invasion remains unknown.
In this study we have shown HIP/PAP is over-expressed in
HCC tissues, positive HIP/PAP expression was strongly asso-
ciated with poor tumor differentiation, advanced tumor stage,
vascular invasion. These clinical data suggested that HIP/PAP
contributes to malignant progression of HCC. However, longterm follow-up is required to conﬁrm the prognostic role of HIP/
PAP in HCC patients.
Moreover, we determined the functional signiﬁcance of HIP/
PAP knockdown by speciﬁc siRNA in HCC cell lines. The HIP/
PAP expression is low in normal hepatocytes, and increases
greatly in HCC cells. The expression of HIP/PAP is even higher
in Huh7 and Hep3B cells which are highly invasive. We chose
Huh7 and Hep3B cells with high invasiveness for further RNA
interference assay, and as expected HIP/PAP knockdown by
speciﬁc siRNA signiﬁcantly inhibited the migration and inva-
sion of HCC cells.
In conclusion, this study demonstrated HIP/PAP is upregu-
lated in HCC and an indicator of aggressive behaviors of HCC
cells, a key factor participating in the progression of HCC by
promoting invasion and migration, yet the prognostic role of
HIP/PAP and detailed molecular pathways involved in the
pathogenesis should be further explored.
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